Artificial Intelligence Uncovers Link Between Protein Modifications, Mutations, and Disease

A new AI model from Baylor College of Medicine, DeepMVP, reveals how protein modifications influenced by genetic mutations can lead to various diseases, paving the way for targeted therapeutics.
Researchers at Baylor College of Medicine have introduced an innovative AI model, DeepMVP, that brings new understanding to how post-translational modifications (PTMs) of proteins connect genetic mutations with various diseases. Published in Nature Methods, this advanced computational tool significantly surpasses existing models, offering promising avenues for developing targeted therapies. Proteins perform essential roles in the body, from tissue growth to metabolic regulation and immune defense. Their functions are often influenced by PTMs—chemical modifications like phosphorylation or glycosylation that occur after protein synthesis. These modifications dictate a protein’s activity, location, stability, and interactions. When PTMs are abnormal or disrupted due to genetic mutations, they can lead to diseases such as cancer, cardiovascular conditions, and neurological disorders. Understanding where PTMs occur within proteins and how mutations affect these sites is crucial for predicting disease pathways. DeepMVP was trained using the PTMAtlas, a comprehensive database with nearly 400,000 PTM sites across human proteins. This resource was created by meticulous reanalysis of public datasets, enabling the model to recognize patterns in protein sequences associated with PTMs. The model excels in predicting PTM sites and assessing how mutations may alter these modifications. In testing, DeepMVP correctly identified PTM sites in 81% of known cases and accurately predicted the impact of mutations in 97% of instances, outperforming eight other similar tools. Its effectiveness extends to predicting effects in viral proteins, including SARS-CoV-2. The tool’s potential spans numerous fields, including cancer research, neurology, and drug development, expediting understanding of mutation-driven disease mechanisms. DeepMVP is freely accessible to researchers worldwide at deepmvp.ptmax.org, promising to accelerate discoveries and improve therapeutic strategies across various medical disciplines.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Impact of Commercialization on IVF Patient Care and Industry Regulation
The booming IVF industry in Australia raises important questions about patient safety, ethical standards, and equal access amid increasing commercialization and regulatory challenges.
Using Blood Markers GDF-15 and eGFRdiff to Predict Kidney Disease Progression in Diabetes
New research identifies blood biomarkers GDF-15 and eGFRdiff as independent predictors of kidney decline and mortality in diabetes, offering improved risk assessment and early intervention opportunities.
Understanding the Brain-Eating Amoeba and Its Deadly Risks for Swimmers
Learn about Naegleria fowleri, a deadly amoeba found in warm freshwater lakes, its risks, symptoms, and how to stay safe while enjoying natural waters this summer.
Personalized Tuberculosis Treatment Strategies Based on Disease Severity Could Enhance Patient Outcomes
New research advocates for tailoring tuberculosis treatment based on disease severity, promising shorter, more effective therapies, and better patient outcomes. Learn how personalized strategies could transform TB care.